A year ago, they were trading at $1.11. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VVUS at https://www.zacks.com/ap/VVUS
Campbell, CA-based VIVUS, Inc. VVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies to address unmet medical needs. The company's portfolio comprises two drugs, Qsymia for …
A month has gone by since the last earnings report for VIVUS, Inc. VVUS. Shares have lost about 19.8% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's next earnings …
Yahoo!8mon
VIVUS Inc. VVUS reported a loss of 6 cents per share in the third quarter ... In fact, so far this year, VIVUS shares have underperformed the industry. The stock declined 43.4% during the period, while the industry witnessed a gain of 3.1%.
A year ago, they were trading at $1.04. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VVUS at https://www.zacks.com/ap/VVUS